VanderbiltHealth.com: For Patients and Visitors
Vanderbilt University Medical Center: For Employees, Researchers, and Students

Targeted Request for Proposals

Exploring the mechanisms for HIV persistence and the potential for HIV eradication

For complete details click here.

Eligibility: Doctoral-level investigators at nonprofit institutions worldwide

Available Funding: $250,000 Total Costs ($208,333 maximum direct costs plus up to 20% for indirect costs)

Performance Period: Two years starting February 1, 2012.

Deadline: Letters of Intent must be submitted no later than October 25, 2011

Background: This RFP solicits proposals relevant to exploring the mechanisms for HIV persistence and the potential for HIV eradication. Highly active antiretroviral therapy (HAART) has significantly impacted the health of individuals infected with HIV-1. However, if therapy is interrupted, there is a rapid resumption of viral replication. Understanding the mechanisms by which the virus is able to persist in the face of therapy is necessary in order to identify strategies that may interrupt viral persistence and ultimately lead to viral eradication. amfAR wishes to support basic, clinical, and especially translational research exploring the mechanisms whereby HIV infection persists; the chronic nature of viral reservoirs and latency; and barriers to the eradication of HIV, with the potential goal of ultimately eliminating HIV infection.

If you are not able to access the RFP, please e-mail grants@amfar.org for assistance.

Copyright © 2014 by Vanderbilt University Medical Center    |    1211 Medical Center Drive    |    Nashville, TN 37232    |    (615) 322-5000
Vanderbilt University is committed to principles of equal opportunity and affirmative action.
This page was last updated September 29, 2011 and is maintained by Gina Perez